Y-mAbs Therapeutics, Inc.
YMAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30 | -$21 | -$96 | -$55 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $2 |
| Stock-Based Comp. | $15 | $14 | $26 | $19 |
| Change in WC | -$4 | -$20 | -$10 | -$7 |
| Other Non-Cash | $3 | -$1 | $4 | -$62 |
| Operating Cash Flow | -$16 | -$27 | -$76 | -$103 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $62 |
| Investing Cash Flow | $0 | $0 | $0 | $61 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4 | $0 | $0 | $108 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1 |
| Financing Cash Flow | $4 | $0 | $0 | $108 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$11 | -$27 | -$76 | $67 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $79 | $106 | $182 | $115 |
| End Cash | $67 | $79 | $106 | $182 |
| Free Cash Flow | -$16 | -$27 | -$76 | -$104 |